Lixte Biotechnology Holdings, Inc. · NASDAQ:LIXT
Pursglove Geordan Garrett received 350,000 Lixte Biotechnology Holdings, Inc. shares as an award (Form 4)
Traded Jul 1, 2026 · Filed Jul 2, 2026
On Jul 1, 2026, Pursglove Geordan Garrett (Director, CEO and Chairman of the Board) received 350,000 Lixte Biotechnology Holdings, Inc. shares as an award, leaving 700,000 shares. Filed Jul 2, 2026 (Form 4).
- Awarded
- 350,000 shares
- Holding after
- 700,000 shares
- Trading plan
- No
- Role
- Director, CEO and Chairman of the Board
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Award | 350,000 | 700,000 | Direct |
Source
Related
- Lixte Biotechnology Holdings, Inc.
- Pursglove Geordan Garrett
- Lixte Biotechnology Holdings, Inc. shareholders
- Form 4 · Pursglove Geordan Garrett · Apr 17, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stazzone Peter · Jul 2, 2026
- Form 4 · Sawyer Jason David · Jul 2, 2026
- Form 4 · Primus Guy Warren · Jul 2, 2026
- Form 4 · Holloway Michael Andrew · Jul 2, 2026